Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2053-6844
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report ; volume:4 ; number:1 ; day:2 ; month:2 ; year:2017 ; pages:1-5 ; date:12.2017
Gynecologic oncology research and practice ; 4, Heft 1 (2.2.2017), 1-5, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Paraghamian, Sarah E.
- Beteiligte Personen und Organisationen
-
Longoria, Teresa C.
Eskander, Ramez N.
SpringerLink (Online service)
- DOI
-
10.1186/s40661-017-0038-9
- URN
-
urn:nbn:de:1111-2017022611719
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Paraghamian, Sarah E.
- Longoria, Teresa C.
- Eskander, Ramez N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma